Exozymes (EXOZ) Enterprise Value (2023 - 2026)
Exozymes (EXOZ) posted quarterly Enterprise Value of -$3.0 million for Q4 2025, up 68.73% year-over-year from -$1.8 million in Q4 2024, and up 40.39% quarter-over-quarter from -$5.1 million in Q3 2025.
Exozymes (EXOZ) Enterprise Value (2023 - 2026) Analysis & Trends
Exozymes (EXOZ) has reported Enterprise Value for 3 consecutive years, with -$3.0 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Enterprise Value rose 68.73% year-over-year to -$3.0 million; the TTM figure through Dec 2025 stood at -$3.0 million (up 68.73% YoY), while the FY2025 annual figure was -$3.0 million, up 68.73% from the prior year.
- Enterprise Value rose to -$3.0 million in Q4 2025 per EXOZ's latest filing, from -$5.1 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$66533.0 in Q4 2023 and bottomed at -$9.7 million in Q4 2024.
- Historically, Enterprise Value has averaged -$4.8 million across 3 years, with a median of -$5.1 million in 2025.
- Annual changes were most pronounced in 2024 — Enterprise Value plunged 14508.25% — and 2025, when it jumped 68.73%.
- Exozymes' Enterprise Value stood at -$66533.0 in 2023, then slumped by 14508.25% to -$9.7 million in 2024, then surged by 68.73% to -$3.0 million in 2025.
- Business Quant data shows EXOZ's Enterprise Value at -$3.0 million in Q4 2025, -$5.1 million in Q3 2025, and -$7.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.29 Bn | 131.44 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 59.49 Bn | 54.36 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 42.02 Bn | 36.92 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 30.79 Bn | 27.48 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 28.26 Bn | 9.87 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.30 Bn | 26.14 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.10 Bn | 26.26 Bn | - | 2.12 Bn |
| 10 | Exozymes | 61.31 Mn | 61.31 Mn | - | -5.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.65 Mn |
| Dec 31, 2025 | -3.04 Mn |
| Sep 30, 2025 | -5.10 Mn |
| Jun 30, 2025 | -6.99 Mn |
| Mar 31, 2025 | -8.16 Mn |
| Dec 31, 2024 | -9.72 Mn |
| Sep 30, 2024 | -233,935.00 |
| Dec 31, 2023 | -66,533.00 |